Mind Medicine (Mind Medicine) Total Stockholders Equity : $196.06 Mil (As of Mar. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Mind Medicine Total Stockholders Equity?

Mind Medicine's Total Stockholders Equity for the quarter that ended in Mar. 2024 was $196.06 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Mind Medicine's Book Value per Share for the quarter that ended in Mar. 2024 was $N/A. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Mind Medicine's Debt-to-Equity for the quarter that ended in Mar. 2024 was 0.07.

Mind Medicine Total Stockholders Equity Historical Data

The historical data trend for Mind Medicine's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mind Medicine Total Stockholders Equity Chart

Mind Medicine Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Total Stockholders Equity

75.87

151.66

150.92

78.13

Mind Medicine Quarterly Data
	Sep19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Stockholders Equity	Get a 7-Day Free Trial													130.34	105.97	95.98	78.13	196.06

Mind Medicine (OTCPK:MMCWF) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Mind Medicine's Book Value per Share for the quarter that ended in Mar. 2024 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(196.059	-	0)	/	0
	=	N/A

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Mind Medicine's Debt-to-Equity for the quarter that ended in Mar. 2024 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0	+	14.19)	/	196.059
	=	0.07

Mind Medicine Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Mind Medicine's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Mind Medicine (Mind Medicine) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Mind Medicine Inc (OTCPK:MMCWF) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

MNMD:USA MMQ:Germany MMED:Canada

Address

One World Trade Center, Suite 8500, New York, NY, USA, 10007

Website

https://www.mindmed.co

Mind Medicine Inc is a psychedelic medicine biotech company that discovers, develops, and deploys psychedelic inspired medicines and therapies to address addiction and mental illness. The company is assembling a compelling drug development pipeline of treatments based on psychedelic substances including Psilocybin, LSD, MDMA, DMT, and an Ibogaine derivative, 18-MC. The firm is having an approach towards developing the next generation of psychedelic inspired medicines and therapies.